2019-2023 Competing in the POC Infectious Disease Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
![](/report_cover/2215/2019-2023-competing-in-poc-infectious-disease-testing-market-supplier-shares-n-segment-forecasts-by-test-competitive-intelligence-emerging-technologies_en.gif)
This new 795-page report from VPGMarketResearch contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Contains 795 pages and 61 tables
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
- Physician Offices/Group Practices
- Emergency Rooms
- Ambulatory Care Centers
- Surgery Centers
- Birth Centers
Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Contains 795 pages and 61 tables
INTRODUCTION
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
@WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis
INSTRUMENTATION: INFECTIOUS DISEASE ANALYZERS MANUFACTURED BY: ABBOTT
Beckman Coulter/Danaher
bioMeriuex
Ortho-Clinical Diagnostics
Roche
Siemens
Tosoh
Wallac, and other suppliers
CURRENT AND EMERGING TECHNOLOGIES
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
C. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
E. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
G. Surgery Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. BIRTH CENTERS
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
J. Major Suppliers’ Instrument Placements, Installed Base, Reagent Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
@WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis
INSTRUMENTATION: INFECTIOUS DISEASE ANALYZERS MANUFACTURED BY: ABBOTT
Beckman Coulter/Danaher
bioMeriuex
Ortho-Clinical Diagnostics
Roche
Siemens
Tosoh
Wallac, and other suppliers
CURRENT AND EMERGING TECHNOLOGIES
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
C. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
E. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
G. Surgery Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. BIRTH CENTERS
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
J. Major Suppliers’ Instrument Placements, Installed Base, Reagent Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
LIST OF TABLES
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers